ESR: Evidence-Based Ways to Improve This Number

The direct answer

ESR cannot be lowered as a goal in itself. It is a downstream readout of plasma fibrinogen and other acute-phase proteins produced by the liver in response to inflammation, infection, tissue injury, or malignancy. A high ESR improves when the process generating those proteins improves, through antibiotics for infection, disease-modifying therapy for autoimmune disease, or resolution of a transient illness. Separately, several lifestyle factors (regular aerobic exercise, weight loss, omega-3 fatty acid intake, and smoking cessation) are associated with modest, real reductions in ESR in the research literature, on the order of single-digit to low-double-digit mm/hr changes over 8 to 16 weeks, but none of these substitutes for identifying why the ESR is elevated in the first place.

What ESR actually measures

ESR measures how quickly red blood cells settle to the bottom of a standardized tube over one hour, reported in millimeters per hour. The rate depends heavily on plasma protein concentration, particularly fibrinogen and immunoglobulins, which promote red cells to stack together (rouleaux formation) and settle faster. When the liver ramps up production of acute-phase proteins during inflammation, ESR rises as a secondary effect. The Westergren method is the long-standing reference technique for this measurement.

ESR does not identify a specific disease. It signals that an inflammatory, infectious, or neoplastic process may be active somewhere in the body. Compared with CRP, ESR rises and falls over days rather than hours, which makes it less useful for tracking rapid changes but sometimes more useful for chronic, low-grade conditions such as polymyalgia rheumatica or giant cell arteritis, where it remains part of standard diagnostic criteria.

Normal ranges and why age and sex matter

Reference ranges for ESR shift with age and sex, and several formulas exist to estimate the upper limit of normal. A commonly cited approach (Miller et al., 1983) sets the ceiling at age ÷ 2 for men and (age + 10) ÷ 2 for women, under this formula a 60-year-old man's upper limit is roughly 30 mm/hr and a 60-year-old woman's is roughly 35 mm/hr. Typical laboratory ranges in practice are:

• Men under 50: roughly 0-15 mm/hr
• Men over 50: roughly 0-20 mm/hr
• Women under 50: roughly 0-20 mm/hr
• Women over 50: roughly 0-30 mm/hr

These are guidelines, not hard cutoffs. Population studies have found that a meaningful minority of healthy adults sit above the age-adjusted upper limit with no identifiable pathology, which is one reason ESR is never interpreted in isolation. Pregnancy raises ESR physiologically, sometimes markedly in the third trimester, because fibrinogen rises independent of any disease process. Anemia of any cause also raises ESR by changing the ratio of red cells to plasma, separate from inflammation.

What causes a high ESR

The differential for an elevated ESR is broad and includes autoimmune disease (rheumatoid arthritis, lupus, polymyalgia rheumatica, giant cell arteritis), infection (endocarditis, osteomyelitis, tuberculosis), malignancy (lymphoma, myeloma, metastatic solid tumors), and obesity, which raises ESR through adipose tissue's secretion of interleukin-6 and downstream fibrinogen production. Very high values (roughly above 100 mm/hr) are associated in clinical experience with infection, connective tissue disease, or cancer more often than with benign causes, though this is a probabilistic pattern rather than a rule, and giant cell arteritis can occasionally present with a normal ESR despite biopsy-proven disease.

If you have a specific numeric threshold or study quoted to you as diagnostic, treat it as a rule of thumb rather than a fixed cutoff, and confirm it against your clinician's interpretation of the full picture, CBC, CRP, symptoms, and exam findings.

What causes a low ESR

A very low ESR (below roughly 1 mm/hr) is less commonly discussed. Polycythemia vera increases red cell mass to the point that settling is physically impeded. Sickle cell disease distorts red cell shape in a way that prevents normal rouleaux formation. Marked leukocytosis can mechanically slow sedimentation, and congestive heart failure can suppress ESR through hemodilution. In most people, however, a low ESR is simply reassuring and reflects the absence of significant systemic inflammation. It does not rule out localized inflammation, since ESR reflects systemic acute-phase protein levels, not what is happening in one joint or organ.

Treating the underlying condition comes first

For a disease-driven elevated ESR, the intervention that actually works is treating the disease. In rheumatoid arthritis, disease-modifying antirheumatic drugs and biologic agents are associated with substantial ESR reductions over weeks to months, and clinicians commonly use ESR trending toward normal as one marker (among several) of treatment response. Corticosteroids can lower ESR within days but carry dose-dependent risks that limit their use as a long-term strategy. Antibiotics resolve infection-driven elevations. NSAIDs blunt ESR modestly through prostaglandin suppression without addressing the process causing it.

None of the lifestyle strategies below are a substitute for this. If ESR is markedly elevated, especially with symptoms such as unexplained fever, weight loss, night sweats, new joint swelling, vision changes, or a new headache in someone over 50, that combination warrants prompt medical evaluation rather than a trial of diet and exercise.

Lifestyle factors associated with lower ESR

The following associations come from a mix of small randomized trials and observational cohorts in the rheumatology and cardiovascular literature. The primary papers behind the specific figures below vary in size and quality, and exact numbers should be verified against the original studies before being used clinically; treat the ranges as directional rather than precise.

Omega-3 fatty acids. Fish oil supplementation has one of the more consistent evidence bases among non-pharmaceutical interventions for ESR, with small randomized trials in rheumatoid arthritis populations reporting reductions in the mid-single to low-double-digit mm/hr range over roughly 8 to 12 weeks at doses of 1.5 to 3 g/day combined EPA and DHA. The proposed mechanism is that EPA and DHA compete with arachidonic acid in eicosanoid synthesis, shifting production toward less inflammatory mediators and reducing hepatic acute-phase protein output.

Aerobic exercise. Controlled trials in rheumatoid arthritis patients and observational studies in healthy older adults have both reported ESR reductions with sustained moderate-intensity aerobic activity (roughly 150 minutes per week) over 8 to 16 weeks, in the single-digit to low-double-digit mm/hr range. The American Heart Association's general recommendation of 150 minutes per week of moderate-intensity aerobic activity aligns with the doses used in this research (AHA, Circulation). The proposed mechanisms include reduced visceral fat (a source of IL-6), anti-inflammatory myokine release from working muscle, and improved insulin sensitivity.

Weight loss. Cohort studies have linked higher BMI to modestly higher ESR, and bariatric surgery series have reported meaningful ESR reductions alongside large amounts of weight loss over 12 months. A reasonable, evidence-consistent initial target for most people is 5 to 10% body weight reduction through diet and exercise rather than surgery, with any ESR effect building gradually rather than immediately.

Mediterranean-style diet. The Mediterranean dietary pattern, rich in fatty fish, extra-virgin olive oil, vegetables, legumes, and whole grains, has trial evidence (including sub-analyses of the PREDIMED trial) for reducing fibrinogen and other inflammatory markers over about a year. Fibrinogen is the main protein driving ESR elevation, so a meaningful fibrinogen reduction plausibly corresponds to a modest ESR reduction, though ESR itself was not the primary endpoint in that trial and this link is inferred rather than directly measured.

Smoking cessation. Current smoking is associated with higher ESR through vascular damage, elevated fibrinogen, higher white cell counts, and chronic airway inflammation, with a dose-dependent relationship to cigarettes per day in cross-sectional data. Fibrinogen begins falling within weeks of quitting and approaches non-smoker levels over several months; ESR is expected to follow a similar trajectory. The CDC identifies smoking cessation as one of the most effective single interventions for reducing inflammatory and cardiovascular risk (CDC, Smoking Cessation: A Report of the Surgeon General, 2020).

When a low ESR needs attention

A persistently suppressed ESR in someone with no symptoms requires no action. It becomes relevant only alongside other abnormal findings: elevated hemoglobin and hematocrit (raising the question of polycythemia vera, for which JAK2 V617F testing is the standard next step), known or suspected sickle cell disease, or marked leukocytosis from leukemia or severe infection. A low ESR in an otherwise healthy, asymptomatic person is not a disease state and is not something to try to "fix."

How often to recheck

Monitoring frequency depends on context, not a fixed schedule. In known autoimmune disease, ESR is typically rechecked every 1 to 3 months during active treatment changes and every 3 to 6 months in stable remission, at the clinician's discretion. When a new inflammatory condition is being worked up, a single value is a baseline, and repeating it in 2 to 4 weeks helps distinguish a transient elevation (recent viral illness, for example) from a persistent one. For lifestyle interventions, 8 to 12 weeks is a reasonable interval before expecting a measurable change, since ESR moves more slowly than CRP. A single mildly elevated reading in someone without symptoms is not, by itself, a reason for alarm or for repeat testing sooner than that.

Evidence boundary: what is established, what is not

Established: ESR is a nonspecific acute-phase marker driven mainly by fibrinogen and other plasma proteins; it rises with active inflammation, infection, and some malignancies, and falls when the underlying process resolves or responds to treatment; reference ranges rise with age and differ by sex; the Westergren method is the standard reference technique.

Plausible but not rigorously established at the ESR level: that omega-3 supplementation, aerobic exercise, weight loss, and a Mediterranean dietary pattern produce clinically meaningful ESR reductions independent of treating an underlying disease. The supporting studies mostly measured fibrinogen, CRP, or ESR in specific populations (often rheumatoid arthritis patients), and the exact magnitude of effect in a general population with a mildly elevated ESR has not been established with the same rigor.

Not established: that any lifestyle change reliably normalizes ESR in the presence of an active, undiagnosed inflammatory or neoplastic condition, or that a specific numeric ESR reduction from diet or exercise translates into a specific reduction in disease risk. ESR is a marker to be interpreted alongside symptoms and other tests, not a target to optimize on its own.

Decision framework: what to do with a high ESR reading

ESR results should serve as a basis for discussion with your healthcare provider rather than being used to diagnose yourself.

The rule underlying this table: lifestyle measures belong in the bottom half of the table, after red flags and disease-specific causes have been considered, not as a first response to any elevated number.